nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—HTR2C—choroid plexus—malignant glioma	0.095	0.159	CbGeAlD
Minaprine—HTR2A—choroid plexus—malignant glioma	0.0477	0.0797	CbGeAlD
Minaprine—DRD1—telencephalic ventricle—malignant glioma	0.0358	0.0599	CbGeAlD
Minaprine—HTR2C—telencephalic ventricle—malignant glioma	0.0278	0.0466	CbGeAlD
Minaprine—HTR2A—cerebellar cortex—malignant glioma	0.024	0.0402	CbGeAlD
Minaprine—DRD2—telencephalic ventricle—malignant glioma	0.0212	0.0354	CbGeAlD
Minaprine—HTR2A—pons—malignant glioma	0.017	0.0284	CbGeAlD
Minaprine—HTR2A—vertebral column—malignant glioma	0.0168	0.0282	CbGeAlD
Minaprine—HTR2A—telencephalic ventricle—malignant glioma	0.014	0.0234	CbGeAlD
Minaprine—HTR2A—pineal body—malignant glioma	0.0121	0.0203	CbGeAlD
Minaprine—DRD1—brainstem—malignant glioma	0.00969	0.0162	CbGeAlD
Minaprine—ACHE—telencephalon—malignant glioma	0.00938	0.0157	CbGeAlD
Minaprine—DRD1—telencephalon—malignant glioma	0.0086	0.0144	CbGeAlD
Minaprine—HTR2C—brainstem—malignant glioma	0.00753	0.0126	CbGeAlD
Minaprine—HTR2A—endothelium—malignant glioma	0.00749	0.0125	CbGeAlD
Minaprine—ACHE—medulla oblongata—malignant glioma	0.00737	0.0123	CbGeAlD
Minaprine—SLC6A4—brainstem—malignant glioma	0.00714	0.0119	CbGeAlD
Minaprine—HTR2A—blood vessel—malignant glioma	0.00691	0.0116	CbGeAlD
Minaprine—ACHE—midbrain—malignant glioma	0.00673	0.0113	CbGeAlD
Minaprine—HTR2C—telencephalon—malignant glioma	0.00668	0.0112	CbGeAlD
Minaprine—ACHE—spinal cord—malignant glioma	0.00657	0.011	CbGeAlD
Minaprine—SLC6A4—telencephalon—malignant glioma	0.00633	0.0106	CbGeAlD
Minaprine—MAOA—embryo—malignant glioma	0.00632	0.0106	CbGeAlD
Minaprine—CHRM1—telencephalon—malignant glioma	0.00631	0.0106	CbGeAlD
Minaprine—HTR2B—telencephalon—malignant glioma	0.00628	0.0105	CbGeAlD
Minaprine—DRD1—midbrain—malignant glioma	0.00618	0.0103	CbGeAlD
Minaprine—MAOA—brainstem—malignant glioma	0.00579	0.00969	CbGeAlD
Minaprine—DRD2—brainstem—malignant glioma	0.00573	0.00958	CbGeAlD
Minaprine—MAOA—retina—malignant glioma	0.00559	0.00935	CbGeAlD
Minaprine—DRD2—retina—malignant glioma	0.00552	0.00924	CbGeAlD
Minaprine—HTR2C—medulla oblongata—malignant glioma	0.00525	0.00879	CbGeAlD
Minaprine—ACHE—cerebellum—malignant glioma	0.00521	0.00872	CbGeAlD
Minaprine—MAOA—telencephalon—malignant glioma	0.00514	0.0086	CbGeAlD
Minaprine—DRD2—telencephalon—malignant glioma	0.00508	0.0085	CbGeAlD
Minaprine—DRD1—central nervous system—malignant glioma	0.00489	0.00818	CbGeAlD
Minaprine—HTR2C—midbrain—malignant glioma	0.0048	0.00803	CbGeAlD
Minaprine—HTR2C—spinal cord—malignant glioma	0.00468	0.00783	CbGeAlD
Minaprine—SLC6A4—midbrain—malignant glioma	0.00455	0.00761	CbGeAlD
Minaprine—SLC6A4—spinal cord—malignant glioma	0.00444	0.00743	CbGeAlD
Minaprine—ACHE—brain—malignant glioma	0.00423	0.00708	CbGeAlD
Minaprine—HTR2A—embryo—malignant glioma	0.00412	0.0069	CbGeAlD
Minaprine—MAOA—medulla oblongata—malignant glioma	0.00404	0.00676	CbGeAlD
Minaprine—DRD1—brain—malignant glioma	0.00388	0.0065	CbGeAlD
Minaprine—HTR2C—central nervous system—malignant glioma	0.0038	0.00636	CbGeAlD
Minaprine—HTR2A—brainstem—malignant glioma	0.00378	0.00632	CbGeAlD
Minaprine—MAOA—midbrain—malignant glioma	0.00369	0.00617	CbGeAlD
Minaprine—DRD2—midbrain—malignant glioma	0.00365	0.00611	CbGeAlD
Minaprine—HTR2A—retina—malignant glioma	0.00364	0.0061	CbGeAlD
Minaprine—SLC6A4—central nervous system—malignant glioma	0.0036	0.00602	CbGeAlD
Minaprine—MAOA—spinal cord—malignant glioma	0.0036	0.00602	CbGeAlD
Minaprine—CHRM1—central nervous system—malignant glioma	0.00359	0.006	CbGeAlD
Minaprine—HTR2B—central nervous system—malignant glioma	0.00357	0.00597	CbGeAlD
Minaprine—CYP2D6—brainstem—malignant glioma	0.00344	0.00576	CbGeAlD
Minaprine—HTR2A—telencephalon—malignant glioma	0.00335	0.00561	CbGeAlD
Minaprine—CYP2D6—telencephalon—malignant glioma	0.00305	0.00511	CbGeAlD
Minaprine—HTR2C—brain—malignant glioma	0.00302	0.00505	CbGeAlD
Minaprine—MAOA—central nervous system—malignant glioma	0.00292	0.00489	CbGeAlD
Minaprine—DRD2—central nervous system—malignant glioma	0.00289	0.00483	CbGeAlD
Minaprine—SLC6A4—brain—malignant glioma	0.00286	0.00478	CbGeAlD
Minaprine—MAOA—cerebellum—malignant glioma	0.00285	0.00478	CbGeAlD
Minaprine—CHRM1—brain—malignant glioma	0.00285	0.00476	CbGeAlD
Minaprine—HTR2B—brain—malignant glioma	0.00283	0.00474	CbGeAlD
Minaprine—DRD2—cerebellum—malignant glioma	0.00282	0.00472	CbGeAlD
Minaprine—HTR2A—medulla oblongata—malignant glioma	0.00263	0.00441	CbGeAlD
Minaprine—Gefitinib—EGFR—malignant glioma	0.00253	1	CrCbGaD
Minaprine—HTR2A—midbrain—malignant glioma	0.00241	0.00403	CbGeAlD
Minaprine—HTR2A—spinal cord—malignant glioma	0.00235	0.00393	CbGeAlD
Minaprine—MAOA—brain—malignant glioma	0.00232	0.00388	CbGeAlD
Minaprine—DRD2—brain—malignant glioma	0.00229	0.00384	CbGeAlD
Minaprine—HTR2A—central nervous system—malignant glioma	0.00191	0.00319	CbGeAlD
Minaprine—HTR2A—cerebellum—malignant glioma	0.00186	0.00312	CbGeAlD
Minaprine—CYP2D6—central nervous system—malignant glioma	0.00174	0.0029	CbGeAlD
Minaprine—CYP2D6—cerebellum—malignant glioma	0.0017	0.00284	CbGeAlD
Minaprine—HTR2A—brain—malignant glioma	0.00151	0.00253	CbGeAlD
Minaprine—CYP2D6—brain—malignant glioma	0.00138	0.00231	CbGeAlD
Minaprine—HTR2B—Signaling by GPCR—EGFR—malignant glioma	5.88e-05	0.000147	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CB—malignant glioma	5.87e-05	0.000147	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	5.84e-05	0.000146	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.84e-05	0.000146	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PDGFRA—malignant glioma	5.84e-05	0.000146	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	5.8e-05	0.000145	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SPP1—malignant glioma	5.76e-05	0.000144	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CXCL8—malignant glioma	5.73e-05	0.000143	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—BRAF—malignant glioma	5.73e-05	0.000143	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CAV1—malignant glioma	5.72e-05	0.000143	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	5.68e-05	0.000142	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SPP1—malignant glioma	5.67e-05	0.000142	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KDR—malignant glioma	5.66e-05	0.000141	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CB—malignant glioma	5.65e-05	0.000141	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CXCL8—malignant glioma	5.64e-05	0.000141	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SPP1—malignant glioma	5.64e-05	0.000141	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	5.62e-05	0.000141	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	5.61e-05	0.00014	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—malignant glioma	5.6e-05	0.00014	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT2—malignant glioma	5.57e-05	0.000139	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—KRAS—malignant glioma	5.56e-05	0.000139	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EGFR—malignant glioma	5.55e-05	0.000139	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL2—malignant glioma	5.48e-05	0.000137	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TERT—malignant glioma	5.46e-05	0.000137	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—F2—malignant glioma	5.45e-05	0.000136	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FN1—malignant glioma	5.45e-05	0.000136	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—FGF2—malignant glioma	5.44e-05	0.000136	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL2—malignant glioma	5.39e-05	0.000135	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—BAD—malignant glioma	5.38e-05	0.000135	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TERT—malignant glioma	5.37e-05	0.000134	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL2—malignant glioma	5.36e-05	0.000134	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CD—malignant glioma	5.36e-05	0.000134	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TERT—malignant glioma	5.34e-05	0.000134	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	5.33e-05	0.000133	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PDGFB—malignant glioma	5.33e-05	0.000133	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—PIK3CA—malignant glioma	5.3e-05	0.000133	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGFR1—malignant glioma	5.3e-05	0.000133	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—KRAS—malignant glioma	5.24e-05	0.000131	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PDGFB—malignant glioma	5.24e-05	0.000131	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CD80—malignant glioma	5.22e-05	0.000131	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HIF1A—malignant glioma	5.22e-05	0.000131	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGFR1—malignant glioma	5.22e-05	0.00013	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.21e-05	0.00013	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	5.21e-05	0.00013	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APC—malignant glioma	5.21e-05	0.00013	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.19e-05	0.00013	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTEN—malignant glioma	5.18e-05	0.00013	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGF—malignant glioma	5.15e-05	0.000129	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HIF1A—malignant glioma	5.14e-05	0.000128	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FGF2—malignant glioma	5.13e-05	0.000128	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTPN11—malignant glioma	5.12e-05	0.000128	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.11e-05	0.000128	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	5.11e-05	0.000128	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MDM2—malignant glioma	5.09e-05	0.000127	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—RAF1—malignant glioma	5.07e-05	0.000127	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CAV1—malignant glioma	5.05e-05	0.000126	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ERBB2—malignant glioma	5.02e-05	0.000125	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KDR—malignant glioma	4.99e-05	0.000125	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CAV1—malignant glioma	4.97e-05	0.000124	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	4.95e-05	0.000124	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CAV1—malignant glioma	4.94e-05	0.000124	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KDR—malignant glioma	4.91e-05	0.000123	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—BRAF—malignant glioma	4.9e-05	0.000123	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KDR—malignant glioma	4.89e-05	0.000122	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTEN—malignant glioma	4.88e-05	0.000122	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	4.82e-05	0.00012	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FN1—malignant glioma	4.81e-05	0.00012	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—F2—malignant glioma	4.81e-05	0.00012	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MDM2—malignant glioma	4.8e-05	0.00012	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RAF1—malignant glioma	4.78e-05	0.00012	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT2—malignant glioma	4.77e-05	0.000119	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCL8—malignant glioma	4.76e-05	0.000119	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—BAD—malignant glioma	4.75e-05	0.000119	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EGFR—malignant glioma	4.75e-05	0.000119	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ERBB2—malignant glioma	4.73e-05	0.000118	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—F2—malignant glioma	4.73e-05	0.000118	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FN1—malignant glioma	4.73e-05	0.000118	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FN1—malignant glioma	4.7e-05	0.000118	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—F2—malignant glioma	4.7e-05	0.000118	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	4.7e-05	0.000118	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTP1—malignant glioma	4.7e-05	0.000118	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—BAD—malignant glioma	4.67e-05	0.000117	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CB—malignant glioma	4.67e-05	0.000117	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—BAD—malignant glioma	4.65e-05	0.000116	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	4.63e-05	0.000116	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CD80—malignant glioma	4.61e-05	0.000115	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	4.6e-05	0.000115	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APC—malignant glioma	4.6e-05	0.000115	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	4.6e-05	0.000115	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	4.59e-05	0.000115	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	4.58e-05	0.000115	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAT—malignant glioma	4.58e-05	0.000114	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—malignant glioma	4.55e-05	0.000114	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGF—malignant glioma	4.55e-05	0.000114	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL2—malignant glioma	4.55e-05	0.000114	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	4.54e-05	0.000113	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CD80—malignant glioma	4.53e-05	0.000113	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APC—malignant glioma	4.53e-05	0.000113	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	4.53e-05	0.000113	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTPN11—malignant glioma	4.52e-05	0.000113	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CD80—malignant glioma	4.51e-05	0.000113	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	4.5e-05	0.000113	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APC—malignant glioma	4.5e-05	0.000113	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—malignant glioma	4.49e-05	0.000112	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	4.49e-05	0.000112	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGF—malignant glioma	4.47e-05	0.000112	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGF—malignant glioma	4.45e-05	0.000111	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTPN11—malignant glioma	4.45e-05	0.000111	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTPN11—malignant glioma	4.42e-05	0.000111	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGF2—malignant glioma	4.39e-05	0.00011	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—malignant glioma	4.33e-05	0.000108	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—BRAF—malignant glioma	4.32e-05	0.000108	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NCOR1—malignant glioma	4.32e-05	0.000108	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—malignant glioma	4.3e-05	0.000108	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—malignant glioma	4.29e-05	0.000107	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL2—malignant glioma	4.29e-05	0.000107	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—malignant glioma	4.28e-05	0.000107	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—BRAF—malignant glioma	4.25e-05	0.000106	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.23e-05	0.000106	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT2—malignant glioma	4.21e-05	0.000105	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—malignant glioma	4.19e-05	0.000105	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—malignant glioma	4.17e-05	0.000104	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT2—malignant glioma	4.14e-05	0.000104	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	4.12e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	4.12e-05	0.000103	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.12e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MDM2—malignant glioma	4.1e-05	0.000103	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.1e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RAF1—malignant glioma	4.09e-05	0.000102	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—malignant glioma	4.06e-05	0.000101	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	4.05e-05	0.000101	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	4.04e-05	0.000101	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—malignant glioma	4.03e-05	0.000101	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	4e-05	0.0001	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	3.99e-05	9.99e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	3.98e-05	9.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—KRAS—malignant glioma	3.96e-05	9.9e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	3.96e-05	9.9e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.94e-05	9.86e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—malignant glioma	3.93e-05	9.84e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	3.92e-05	9.8e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	3.89e-05	9.74e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	3.87e-05	9.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGF2—malignant glioma	3.87e-05	9.68e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	3.86e-05	9.66e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	3.84e-05	9.6e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—malignant glioma	3.83e-05	9.57e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGF2—malignant glioma	3.81e-05	9.53e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGF2—malignant glioma	3.79e-05	9.48e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.71e-05	9.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.67e-05	9.19e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL2—malignant glioma	3.67e-05	9.17e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CA—malignant glioma	3.65e-05	9.14e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—malignant glioma	3.64e-05	9.11e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	3.64e-05	9.1e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MDM2—malignant glioma	3.62e-05	9.06e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RAF1—malignant glioma	3.61e-05	9.03e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—malignant glioma	3.61e-05	9.02e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	3.58e-05	8.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB2—malignant glioma	3.57e-05	8.93e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MDM2—malignant glioma	3.56e-05	8.91e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.56e-05	8.9e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MYC—malignant glioma	3.55e-05	8.89e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RAF1—malignant glioma	3.55e-05	8.88e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MDM2—malignant glioma	3.54e-05	8.87e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.53e-05	8.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	3.52e-05	8.81e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAV1—malignant glioma	3.52e-05	8.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	3.51e-05	8.79e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.49e-05	8.74e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—malignant glioma	3.48e-05	8.69e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.47e-05	8.68e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.47e-05	8.67e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—malignant glioma	3.45e-05	8.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.45e-05	8.63e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CA—malignant glioma	3.44e-05	8.61e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.39e-05	8.47e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	3.37e-05	8.42e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MYC—malignant glioma	3.35e-05	8.38e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.33e-05	8.33e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.31e-05	8.29e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KRAS—malignant glioma	3.28e-05	8.21e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—malignant glioma	3.28e-05	8.2e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.27e-05	8.18e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—malignant glioma	3.24e-05	8.11e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL2—malignant glioma	3.24e-05	8.09e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3.22e-05	8.05e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.21e-05	8.02e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.2e-05	8.01e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—malignant glioma	3.19e-05	7.98e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL2—malignant glioma	3.18e-05	7.96e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.17e-05	7.93e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL2—malignant glioma	3.17e-05	7.92e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	3.12e-05	7.79e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KRAS—malignant glioma	3.1e-05	7.75e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—malignant glioma	3.1e-05	7.74e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—malignant glioma	3.09e-05	7.72e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—malignant glioma	3.06e-05	7.66e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—malignant glioma	3.05e-05	7.62e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	3.02e-05	7.55e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—malignant glioma	3.01e-05	7.54e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—malignant glioma	3e-05	7.5e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—malignant glioma	3e-05	7.49e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—malignant glioma	2.98e-05	7.47e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—malignant glioma	2.98e-05	7.45e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.97e-05	7.43e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.92e-05	7.31e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—malignant glioma	2.92e-05	7.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.91e-05	7.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.87e-05	7.17e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	2.85e-05	7.12e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.82e-05	7.05e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—malignant glioma	2.81e-05	7.03e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.8e-05	7.01e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—malignant glioma	2.75e-05	6.88e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.75e-05	6.88e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.72e-05	6.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.71e-05	6.77e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.69e-05	6.73e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.68e-05	6.7e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.67e-05	6.67e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.65e-05	6.63e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MYC—malignant glioma	2.53e-05	6.33e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.49e-05	6.23e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MYC—malignant glioma	2.48e-05	6.19e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.48e-05	6.19e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—malignant glioma	2.46e-05	6.16e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.46e-05	6.15e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.44e-05	6.09e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.44e-05	6.09e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.43e-05	6.09e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.42e-05	6.06e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.35e-05	5.89e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.34e-05	5.85e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—malignant glioma	2.32e-05	5.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.3e-05	5.75e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.29e-05	5.72e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.15e-05	5.37e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—malignant glioma	2.12e-05	5.31e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	2.11e-05	5.29e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.1e-05	5.26e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—malignant glioma	2.08e-05	5.2e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—malignant glioma	2.04e-05	5.11e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—malignant glioma	2.03e-05	5.09e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.99e-05	4.97e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.75e-05	4.39e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.73e-05	4.32e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.72e-05	4.3e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.5e-05	3.75e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—malignant glioma	1.22e-05	3.06e-05	CbGpPWpGaD
